UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge

Journal of Virology, 2009-06, Vol.83 (11), p.5726-5734

2009

Volltextzugriff (PDF)

Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection

Scientific reports, 2022-09, Vol.12 (1), p.14971-14971, Article 14971

2022

Volltextzugriff (PDF)

17β-Estradiol restores antibody responses to an influenza vaccine in a postmenopausal mouse model

Vaccine, 2011-03, Vol.29 (14), p.2515-2518

2011

Volltextzugriff (PDF)

Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations

Journal of Clinical Microbiology, 2011-06, Vol.49 (6), p.2210-2215

2011

Volltextzugriff (PDF)

Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization

Journal of Virology, 2006-02, Vol.80 (4), p.1959-1964

2006

Volltextzugriff (PDF)

Seroprevalence of antibodies to avian influenza A (H5) and A (H9) viruses among market poultry workers, Hanoi, Vietnam, 2001

PloS one, 2012-08, Vol.7 (8), p.e43948

2012

Volltextzugriff (PDF)

Evaluation of a Genetically Modified Reassortant H5N1 Influenza A Virus Vaccine Candidate Generated by Plasmid-Based Reverse Genetics

Virology (New York, N.Y.), 2003-01, Vol.305 (1), p.192-200

2003

Volltextzugriff (PDF)

Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses

PloS one, 2009-05, Vol.4 (5), p.e5476-e5476

2009

Volltextzugriff (PDF)

Characterization of Highly Pathogenic H5N1 Avian Influenza A Viruses Isolated from South Korea

Journal of Virology, 2005-03, Vol.79 (6), p.3692-3702

2005

Volltextzugriff (PDF)

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses

Vaccine, 2006-11, Vol.24 (44), p.6588-6593

2006

Volltextzugriff (PDF)

A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans

Journal of Virology, 1999-07, Vol.73 (7), p.5903-5911

1999

Volltextzugriff (PDF)

Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans

Journal of Virology, 2000-07, Vol.74 (13), p.6105-6116

2000

Volltextzugriff (PDF)

Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections

PloS one, 2010-05, Vol.5 (5), p.e10583-e10583

2010

Volltextzugriff (PDF)

The clinical application of camrelizumab on advanced hepatocellular carcinoma

Expert review of gastroenterology & hepatology, 2020-11, Vol.14 (11), p.1017-1024

2020

Volltextzugriff (PDF)

Molecular Correlates of Influenza A H5N1 Virus Pathogenesis in Mice

Journal of Virology, 2000-11, Vol.74 (22), p.10807-10810

2000

Volltextzugriff (PDF)

Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors

Expert review of anticancer therapy, 2021-09, Vol.21 (9), p.917-926

2021

Volltextzugriff (PDF)

Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses

Journal of immunological methods, 2011-06, Vol.369 (1), p.115-124

2011

Volltextzugriff (PDF)

Influenza virus titration, antigenic characterization, and serological methods for antibody detection

Methods in molecular biology (Clifton, N.J.), 2012, Vol.865, p.25

2012

Volltextzugriff (PDF)

A marine algicidal Thalassospira and its active substance against the harmful algal bloom species Karenia mikimotoi

Applied microbiology and biotechnology, 2016-06, Vol.100 (11), p.5131-5139

2016

Volltextzugriff (PDF)

Immunity to influenza: the challenges of protecting an aging population

Immunologic research, 2004-01, Vol.29 (1-3), p.113-124

2004

Volltextzugriff (PDF)

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate

Vaccine, 2003-05, Vol.21 (17), p.1974-1979

2003

Volltextzugriff (PDF)

Positive selection of a pre-expansion CAG repeat of the human SCA2 gene

PLoS genetics, 2005-09, Vol.1 (3), p.e41-e41

2005

Volltextzugriff (PDF)

Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains

Vaccine, 2016-01, Vol.34 (4), p.495-502

2016

Volltextzugriff (PDF)

Immunity to Influenza A H9N2 Viruses Induced by Infection and Vaccination

Journal of Virology, 2001-05, Vol.75 (10), p.4896-4901

2001

Volltextzugriff (PDF)

A cationic liposome–DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets

Virology (New York, N.Y.), 2016-05, Vol.492, p.197-203

2016

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

ThemaInfectious Diseases

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(117)

Publikationsform

Artikel
(127)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Intranasal Vaccination with 1918 Influenza Virus-Like Particles Protects Mice and Ferrets from Lethal 1918 and H5N1 Influenza Virus Challenge

Low quality antibody responses in critically ill patients hospitalized with pandemic influenza A(H1N1)pdm09 virus infection

17β-Estradiol restores antibody responses to an influenza vaccine in a postmenopausal mouse model

Sensitivity and Specificity of Serologic Assays for Detection of Human Infection with 2009 Pandemic H1N1 Virus in U.S. Populations

Protection of Mice and Poultry from Lethal H5N1 Avian Influenza Virus through Adenovirus-Based Immunization

Seroprevalence of antibodies to avian influenza A (H5) and A (H9) viruses among market poultry workers, Hanoi, Vietnam, 2001

Evaluation of a Genetically Modified Reassortant H5N1 Influenza A Virus Vaccine Candidate Generated by Plasmid-Based Reverse Genetics

Generation, characterization and epitope mapping of two neutralizing and protective human recombinant antibodies against influenza A H5N1 viruses

Characterization of Highly Pathogenic H5N1 Avian Influenza A Viruses Isolated from South Korea

Cross-protective immunity in mice induced by live-attenuated or inactivated vaccines against highly pathogenic influenza A (H5N1) viruses

A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans

Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans

Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections

The clinical application of camrelizumab on advanced hepatocellular carcinoma

Molecular Correlates of Influenza A H5N1 Virus Pathogenesis in Mice

Surufatinib for the treatment of advanced extrapancreatic neuroendocrine tumors

Development and evaluation of an M2-293FT cell-based flow cytometric assay for quantification of antibody response to native form of matrix protein 2 of influenza A viruses

Influenza virus titration, antigenic characterization, and serological methods for antibody detection

A marine algicidal Thalassospira and its active substance against the harmful algal bloom species Karenia mikimotoi

Immunity to influenza: the challenges of protecting an aging population

Generation and evaluation of a high-growth reassortant H9N2 influenza A virus as a pandemic vaccine candidate

Positive selection of a pre-expansion CAG repeat of the human SCA2 gene

Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains

Immunity to Influenza A H9N2 Viruses Induced by Infection and Vaccination

A cationic liposome–DNA complexes adjuvant (JVRS-100) enhances the immunogenicity and cross-protective efficacy of pre-pandemic influenza A (H5N1) vaccine in ferrets

Aktive Filter

Suchergebnisse filtern